Fallo et al. reported that the glucocorticoids decreased plasma adiponectin levels in males, as shown in both healthy subjects receiving acute exogenous administration and patients with chronic endogenous hypercortisolism [30]. Here, ADIPOQ is linked to adrenal gland hyperfunction.